BofA Securities Maintains Catalyst Pharmaceuticals(CPRX.US) With Buy Rating, Announces Target Price $27

Futu NewsOct 18 17:33 · Ratings

Zacks.com Featured Highlights Include Barrick Gold, Catalyst Pharmaceuticals, Allegiant Travel and America Movil

Zacks Oct 15 21:35

Unlock Your Portfolio Value With These 4 High Earnings Yield Stocks

Zacks Oct 14 20:30

Capricor Reports Positive Long-term Data for DMD Drug Deramiocel

Seeking AlphaOct 12 00:41

Catalyst Pharmaceuticals Inc (CPRX) Q2 2024 Earnings Call Highlights: Revenue Surge and ...

InvestingOct 9 23:34

Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts

GlobeNewswireOct 8 20:03